Early biomarkers may predict Alzheimer’s onset

Nov 2, 2021 by

New research published in the journal EMBO Molecular Medicine has revealed that circulating microRNAs, which are easily measured blood proteins, may identify the early risk of Alzheimer’s. Targeting these microscopic nucleotides for therapy could delay the onset of dementia by inhibiting cellular damage in the brain.